Draft:Pediatric Endocrine Society

The Pediatric Endocrine Society (PES) is a professional medical association. It was founded in 1972 as the Lawson Wilkins Pediatric Endocrine Society. The organization celebrated turning 50 in 2022.

Thomas Carpenter, MD is the current president (2024). The organization is based in Washington D.C. Pediatric Endocrine Society (PES) 2024 Annual Meeting is taking place May 2-5, 2024, in Chicago, IL. The society has a membership count of between 1500-1600 members.

In August 2015, the Pediatric Endocrine Society released recommendations for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children.

In April 2019, PES responded to a request by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) with endocrine funding priorities; obesity and diabetes were at the top of the list.

In 2021, PES offered updated recommendations for use of growth-promoting hormone therapy and related medications in children. The Guidelines for Growth Hormone and Insulin-Like Growth Factor-1 Treatment in Children and Adolescents were updated from 2003 and reflect the continuing controversy over how to diagnose, categorize and treat growth failure in children. The guideline was developed following the GRADE approach (Grading of Recommendations, Assessment, Development, and Evaluation). PES has a resource center dedicated to Growth Hormone Deficiency (GHD).

In April 2021, PES released a position statement in support of Gender Affirming Care (GAC). In it it states, "Puberty suppression and/or gender-affirming hormone therapy is recommended within this evidence-based approach on a case-by-case basis as medically necessary and is potentially lifesaving." This position is at odds with the position of England's National Health Service (NHS) which maintains that evidence for puberty blockers and hormone treatment for gender transition wholly is inadequate, and has decided to stop routine prescribing of puberty blockers.

In February 2023 Nicole Glaser, a pediatric endocrinologist from UC Davis received the Senior Researcher Award from the Pediatric Endocrine Society.

In May 2023, PES held its annual meeting in San Diego, CA. Abstracts included the following topics: Adrenal, Bone and Mineral, Diabetes – type 1, Diabetes – type 2, Equity, Diversity, and Inclusion, Fetal and Neonatal Endocrinology and Metabolism, Genetic Syndromes, Growth and GH/IGF Axis, Lipids, Multisystem Endocrine Disorders, Neuroendocrinology/Hypothalamic Pituitary, Obesity, PCOS, Puberty, Quality Improvement/Education, Sex Differentiation/Gonads and DSD, Thyroid, Transgender Health and Transition to Adult Care.